CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection

Affiliations

¹ Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.
² Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
³ Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Würzburg, Germany.
⁴ Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany. buck_a@ukw.de.
⁵ Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany. werner_r1@ukw.de.
⁶ Division of Nuclear Medicine and Molecular Imaging, The Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA. werner_r1@ukw.de.

^# Contributed equally.

Alessandro Lambertini et al. Eur J Nucl Med Mol Imaging. 2022 Dec.

. 2022 Dec;50(1):228-229.

doi: 10.1007/s00259-022-05932-4. Epub 2022 Aug 12.

¹ Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.
² Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
³ Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Würzburg, Germany.
⁴ Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany. buck_a@ukw.de.
⁵ Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany. werner_r1@ukw.de.
⁶ Division of Nuclear Medicine and Molecular Imaging, The Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA. werner_r1@ukw.de.

^# Contributed equally.

No abstract available

Conflict of interest statement

The authors declare no competing interests.

1. Silvin A, Chapuis N, Dunsmore G, Goubet AG, Dubuisson A, Derosa L, et al. Elevated Calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell. 2020;182(1401–18):e18. doi: 10.1016/j.cell.2020.08.002. - DOI - PMC - PubMed
1. Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20:e276–e288. doi: 10.1016/S1473-3099(20)30651-4. - DOI - PMC - PubMed
1. Albano D, Bertagna F, Bertoli M, Bosio G, Lucchini S, Motta F, et al. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high-prevalence region. J Nucl Med. 2020;61:632–636. doi: 10.2967/jnumed.120.246256. - DOI - PubMed
1. Bouter C, Meller B, Sahlmann CO, Staab W, Wester HJ, Kropf S, et al. (68)Ga-Pentixafor PET/CT imaging of chemokine receptor CXCR4 in chronic infection of the bone: First insights. J Nucl Med. 2018;59:320–326. doi: 10.2967/jnumed.117.193854. - DOI - PubMed
1. Werner RA, Koenig T, Diekmann J, Haghikia A, Derlin T, Thackeray JT, et al. CXCR4-targeted imaging of post-infarct myocardial tissue inflammation: Prognostic value after reperfused myocardial infarction. JACC Cardiovasc Imaging. 2022;15:372–374. doi: 10.1016/j.jcmg.2021.08.013. - DOI - PubMed